Skip to main content

Advertisement

Log in

The Effect of Preoperative Vitamin K on the INR in Bridging Therapy

  • Original Article
  • Published:
International Journal of Hematology Aims and scope Submit manuscript

Abstract

We investigated a bridging protocol using oral Vitamin K three days before scheduled surgery. 60 patients in two bridging protocols, 30 cases per protocol. The first cohort (Control group) had its warfarin held on Day-5 (five days before surgery). The intervention cohort (Vitamin K group) routinely received 2.5 mg of oral Vitamin K on Day-3 but was otherwise identically bridged. Primary outcome was INR on Day-1. Secondary outcomes included patients with INRs ≥1.5 on Day-1, bleeding episodes and elevated INR post surgery. Day-1 INR for the Vitamin K group was 1.16, vs. 1.28 for the Control group (p = 0.037). Postoperative INR was similar. Only the Control group had patients with INRs ≥1.5 on Day-1, or patients with significant bleeding. Adding Vitamin K on Day-3 leads to a safe preoperative INR and may limit other complications.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Douketis JD, Spyropoulos AC, Spencer FA, et al. Perioperative management of antithrombotic therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012;141(2 suppl):e326S–50S.

    PubMed Central  CAS  PubMed  Google Scholar 

  2. Kovacs MJ, Kearon C, Rodger M, et al. Single-arm study of bridging therapy with low-molecular-weight heparin for patients at risk of arterial embolism who require temporary interruption of warfarin. Circulation. 2004;110:1658–63.

    Article  CAS  PubMed  Google Scholar 

  3. Woods K, Douketis JD, Kathirgamanathan K, Yi Q, Crowther MA. Low-dose oral Vitamin K to normalize the international normalized ratio prior to surgery in patients who require temporary interruption of warfarin. J Thromb Thrombolysis. 2007;24:93–7.

    Article  CAS  PubMed  Google Scholar 

  4. Garcia D, Alexander JH, Wallentin L, Wojdyla DM, Thomas L, Hanna M, Al-Khatib, M, Dorian P, Ansell J, Commerford P, Flaker G, Lanas F, Vinereanu D, Xavier D, Hylek EM, Held C, Verheugt FW, Granger CB, Lopes RD. Management and clinical outcomes in patients treated with apixaban versus warfarin undergoing procedures. Blood. 2014; 124(25):3692–8. doi:10.1182/blood-2014-08-595496.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  5. Dentali F, Marchesi C, Pierfranceschi MG, et al. Safety of prothrombin complex concentrates for rapid anticoagulation reversal of vitamin K antagonists. A meta-analysis. Thromb Haemost. 2011;106(3):429–38.

    Article  CAS  PubMed  Google Scholar 

  6. Burbury KL, Milner A, Snooks B, Jupe D, Westerman DA. Short-term warfarin reversal for elective surgery—using low-dose intravenous vitamin K: safe, reliable and convenient. Br J Haematol. 2011;154:626–34.

    Article  CAS  PubMed  Google Scholar 

  7. Schulman S, Healey JS, Douketis JD, Delaney J, Morillo CA. Reduced-dose warfarin or interrupted warfarin with heparin bridging for pacemaker or defibrillator implantation: a randomized trial. Thromb Res. 2014;134(4):818–8. doi:10.1016/j.thromres.2014.07.028

    Article  CAS  PubMed  Google Scholar 

  8. Whitlock RP, Crowther MA, Warkentin TE, Blackall MH, Farrokhyar F, Teoh KH. Warfarin cessation before cardiopulmonary bypass: lessons learned from a randomized controlled trial of oral vitamin K. Ann Thorac Surg. 2007;84:103–8.

    Article  PubMed  Google Scholar 

  9. Steib A, Barre J, Mertes M, et al. Can oral vitamin K before elective surgery substitute for preoperative heparin bridging in patients on vitamin K antagonists? J Thromb Haemostas. 2010;8:499–503.

    Article  CAS  Google Scholar 

  10. Crowther MA, Ageno W, Schnurr T, et al. Oral vitamin K produces a normal INR within 24 hours of its administration in most patients discontinuing warfarin. Haematologica. 2005;90:137–9.

    CAS  PubMed  Google Scholar 

  11. Schulman S, Elbazi R, Zondag M, O’Donnell M. Clinical factors influencing normalization of prothrombin time after stopping warfarin: a retrospective cohort study. Thromb J. 2008;6:15.

    Article  PubMed Central  PubMed  Google Scholar 

Download references

Conflict of interest

There are no conflicts of interest to report for any of the authors.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Henny Heisler Billett.

Additional information

Source of support: Albert Einstein College of Medicine Senior Research Fellowship, 2012. All authors had access to the data and a role in writing the manuscript.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bayewitz, A., Scorziello, B., Maala, C. et al. The Effect of Preoperative Vitamin K on the INR in Bridging Therapy. Int J Hematol 101, 264–267 (2015). https://doi.org/10.1007/s12185-015-1744-x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12185-015-1744-x

Keywords

Navigation